HER2 Positive Breast Cancer By TP Sahoo
Session 3 : HER2 Positive Breast Cancer
Chairpersons :
D C Doval, CJ Tamane
Speaker :
TP Sahoo
“ORAL Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2 positive cohort of the Gepar Quinto study (GBG 44)”
Author: M. Untch
Conference: ESMO
Five-year analysis of the phase II NeoSphere trial evaluating four cycles of neoadjuvant docetaxel (D) and/ or trastuzumab (T) and/ or pertuzumab (P)
Author: L. Gianni
Conference: ASCO